SNS Research
Menu
Introducing SNS Market Intelligence Portal
Picture
The SNS Market Intelligence Platform integrates structured market forecasts with clinical development pipeline data in a single, interactive environment. This enables life sciences organizations to evaluate commercial opportunity, assess competitive risk, and align clinical and market strategy with greater precision across development and launch timelines.

Healthcare & Pharma Reports
SNS MArket Intelligence
Drug Development Pipelines

For Enquiries, Demo & Trial Requests please contact: [email protected]

Featured Research

Picture
The Ophthalmic Drugs Market 2026 to 2036: Disease Landscape, Pipeline, Commercial Dynamics and Forecasts​

Release Date: May 2026 
Number of Pages: 365 
Tables and Figures: 86

Companies Profiles: 116 
Pipeline Candidates: 141


The “Ophthalmic Drugs Market 2026 to 2036: Disease Landscape, Pipeline, Commercial Dynamics and Forecasts” report provides a comprehensive assessment of the global ophthalmic drugs market from 2026 to 2036, covering the disease landscape, R&D pipeline, competitive dynamics, biosimilar competition, delivery innovation, and strategic outlook.
The report additionally includes profiles and strategies of leading ophthalmic drug developers, biopharmaceutical companies, biosimilar manufacturers, and specialist biotechs active across the value chain.
​Market size forecasts are segmented across 6 therapeutic categories, 5 routes of administration, 3 distribution channels, 4 drug types, 2 prescription status categories, 3 patent status categories, 5 regional markets, and 26 country markets. The pipeline analysis covers 140 active candidates across six mechanistic classes and four strategic classifications. The report is accompanied by an Excel datasheet suite covering all quantitative forecast data and the full pipeline dataset. 


For Enquiries, Sample Pages and Table of Contents Please Contact: [email protected]

Trending Research Reports

Psoriasis Drugs Market: 2025
Dermatological Drugs Market: 2025
Skin Cancer Drugs Market: 2025
Digital Health: 2024
The Cancer Drugs Market: 2023-2033
Pre-Filled Syringes Market: 2023 - 2033
The mHealth (Mobile Healthcare) Ecosystem 2022
The Generic Drugs Market
The Glaucoma Drugs Market

    ​Subscribe to our Newsletter

Submit

​​Client Testimonial

The SNS report covering “The Dermatological Drugs Market” is an invaluable one stop resource for plethora of information regarding the dermatological market. This report provides comprehensive view to both the business aspect as well as to the clinical one of the Derma market. It constitutes both an introduction to the various indications targeted at all that may want to enter into this vastly growing market, as well as to the commercial aspect of it, offering an encompassing analysis of the main players, the economics. Moreover, with its 15 years vision, it provides thoughtful projections into the future.
Nadav Schreibom, CEO, Sirbal LTD.

Search Website


Notable Customers


Media Coverage
Valeant Pharmaceuticals refers forecasts from our Glaucoma Drugs Report (Page 7)

Outlook Therapeutics features our Biosimilars Report in their IPO document (Page77-79)
​
Drug Development references findings from our Prefilled Syringes Market Report (Page 31)

Optometery Today by Association of Optometrists refers to our Ophthalmic Drugs Market Report

Air Cargo Eye refers to our Dermatological Drugs Market Report

​
Clarkson Consulting refers to our mHealth Forecasts in the Life Sciences Trends Report


Outsiders Club refers to our Generic Drugs research
Press Releases
SNS Research launches SNS Market Intelligence Platform now allowing secure digital dashboard access comprehensive pharmaceutical market data, pipeline analysis, and regional insights.

SNS Research Publishes Comprehensive 2025–2035 Global Dermatological Drugs Market Report​

Psoriasis Drugs Market to Reach 20 Billion Dollars in 2025 as SNS Research Releases Comprehensive 2025–2035 Industry Outlook

The global dermatological drug market is poised for substantial growth, driven by an increasing prevalence of skin disorders worldwide and a surge in the development of innovative therapies, according to a new report by SNS Research.


SNS Research reveals the digital health market will surpass $243 billion by 2024, as innovations in wearables, AI, and telehealth empower patients and revolutionize care delivery.

Our Research & Services

​Pharma Research Library
​Clinical Pipeline Datasets
Request Clinical Pipeline Data
Send an Inquiry
Purchase Report

Company

Home
​Our Customers
Press Releases
​​About Us 
​Media Coverage

More

Subscribe for Latest Updates
​Privacy Policy
​Disclosures
​
​​               Contact Us: [email protected] ​ ​                                     © 2026 SNS Research  ​
  • Home
  • Privacy Policy
  • Our Customers
  • Media Coverage
  • Press Releases
    • SNS Market Intelligence Platform PR
  • About Us
  • Contact Us
  • Pharma Reports
    • Drug Development Pipelines
  • Dermatological Drugs Market
  • Psoriasis Drugs Market
    • Psoriasis Drugs Pipeline
  • Digital Health Market
  • Skin Cancer Drugs Market 2025
  • Home
  • Privacy Policy
  • Our Customers
  • Media Coverage
  • Press Releases
    • SNS Market Intelligence Platform PR
  • About Us
  • Contact Us
  • Pharma Reports
    • Drug Development Pipelines
  • Dermatological Drugs Market
  • Psoriasis Drugs Market
    • Psoriasis Drugs Pipeline
  • Digital Health Market
  • Skin Cancer Drugs Market 2025